AlphaCognition
Alpha Cognition is a clinical stage, biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer鈥檚 Dementia and Amyotrophic Lateral Sclerosis (ALS).
4
Funding Rounds
$12.3m
Money raised
Overview
Alpha Cognition is a clinical stage, biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer鈥檚 Dementia and Amyotrophic Lateral Sclerosis (ALS).
-
Website:
- Social accounts:
Industries
AlphaCognition is active in the following industries: